Studies have also shown that BM2-241027 reduces axonal dysfunction, neurotoxicity, cognitive deficits, and AD-like pathology in PS19 aged tau transgenic mice (Zhang et al., 2012). This evidence concerns the gene MAPT and Alzheimer disease.